Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma, Ling Su
Springer Nature ·
2025-05-09
· DOI 10.1186/s12885-025-14227-4
The publisher did not provide an abstract — full text is available via the link below.
Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma et al. Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14227-4. – URL: https://doi.org/10.1186/s12885-025-14227-4
Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma, & Ling Su (2025). Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. BMC Cancer. https://doi.org/10.1186/s12885-025-14227-4
Zhenpo Zhang, et al. “Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database.” BMC Cancer, 2025. doi:10.1186/s12885-025-14227-4.
@article{Zhang2025,
title = {Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database},
author = {Zhang, Zhenpo and Zheng, Jingping and Liang, Yankun and Wu, Qimin and Ding, Chufeng and Ma, Lin and Su, Ling},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14227-4},
url = {https://doi.org/10.1186/s12885-025-14227-4}
}